The needle-free drug delivery devices market size is projected to reach US$ 28.42 billion by 2031 from US$ 14.76 billion in 2023. The market is expected to register a CAGR of 8.5% in 2023–2031. Rise in strategic initiatives, and use of healthcare integration software are likely to remain key needle-free drug delivery devices market trends.
Needle-Free Drug Delivery Devices Market Analysis
Needles can lead to various diseases, such as HIV, and injuries if not administered with proper precautions. According to the article “MEDICSEN: NEEDLE-FREE SMARTPATCH FOR PAINLESS DRUG DELIVERY’, over 2,000 people in the US are affected by needlestick injuries per day, generating over US$ 3 billion in associated costs every year. The use of needle-free drug delivery devices decreases the chances of these injuries and diseases. Thus, a surge in the prevalence of needlestick injuries and a rise in spending for treatment fuels the growth of the needle-free drug delivery devices market
Needle-Free Drug Delivery Devices Market Overview
Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Needle-Free Drug Delivery Devices Market: Strategic Insights
Market Size Value in US$ 14.76 billion in 2023 Market Size Value by US$ 28.42 billion by 2031 Growth rate CAGR of 8.5% from 2024 to 2031 Forecast Period 2024-2031 Base Year 2023
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Needle-Free Drug Delivery Devices Market: Strategic Insights
| Market Size Value in | US$ 14.76 billion in 2023 |
| Market Size Value by | US$ 28.42 billion by 2031 |
| Growth rate | CAGR of 8.5% from 2024 to 2031 |
| Forecast Period | 2024-2031 |
| Base Year | 2023 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Needle-Free Drug Delivery Devices Market Drivers and Opportunities
Rising Prevalence of Chronic Diseases and Lifestyle Disorders to Favor Market
Chronic diseases such as heart disease, diabetes, and cancer are the leading causes of death and disability worldwide. As per the Centers for Disease Control and Prevention (CDC), ~38.4 million people in America were suffering from diabetes in 2021. To control the incidence of diabetes, insulin is injected through the subcutaneous layer at regular intervals. Due to an increase in the prevalence of diabetes, the demand for insulin injections is also growing. The companies are focusing on developing needle-free insulin devices to avoid needlestick injuries. For instance, Medicsen is focusing on developing SmartPatch to deliver insulin with more efficacy.
Rising Preference for Home Healthcare – An Opportunity for Needle-Free Drug Delivery Market
A shift from hospitals, long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in greater chances of better, consistent, and timely interaction between patient and doctor owing to the growing utilization of cloud and mobility-driven medical devices. In developing countries, the number of patients receiving home therapy has been limited in the past. The smart patches and jet injectors are integrated with electronic health records (EHR), allows doctors to monitor the dosage for anywhere. With the help of needle-free drug delivery devices, the patient can easily self-administer their drugs according to the requirements prescribed by the doctor. Thus, an increase in focus on home healthcare and the use of technologically integrated products is expected to act as an opportunity for growth of the market during the forecast period.
Needle-Free Drug Delivery Devices Market Report Segmentation Analysis
Key segments that contributed to the derivation of the needle-free drug delivery devices market analysis are type and application.
- Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others. The jet injectors segment held the largest market share in 2023.
- By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.
Needle-Free Drug Delivery Devices Market Share Analysis by Geography
The geographic scope of the needle-free drug delivery devices market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America.
North America dominated the needle-free drug delivery devices market in 2023. The market growth in North America is characterized by increased demand for rare disease medications from biopharmaceutical and biotechnology companies, the presence of key market players, an increase in product launches, a rise in the burden of needle stick injuries, and extensive R&D conducted by academic and research institutes and pharmaceutical and biotechnology companies. Moreover, Asia Pacific is anticipated to record the highest CAGR in the coming years.
Needle-Free Drug Delivery Devices Market News and Recent Developments
The needle-free drug delivery devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for needle-free drug delivery devices and strategies:
- NovaXS, which was formed at the University of California, Berkeley, designed its patent-pending Telosis technology to administer a narrow stream of medication without a needle in 0.3 seconds and to analyze injection data to allow for smarter health decisions. (Source: NovaXS BIotech, Press Release, 2022)
- NuGen Medical Devices Inc. launched InsuJet devices in Canada. SOL-MILLENNIUM Medical Group has registered as an exhibitor at the 2022 Diabetes Canada/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference, where it launched the InsuJet product for Canada. (Source: NuGen Medical Devices Inc, Company Website, 2022)
Needle-Free Drug Delivery Devices Market Report Scope
Needle-Free Drug Delivery Devices Market Report Coverage and Deliverables
The “Needle-Free Drug Delivery Devices Market Size and Forecast (2023–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The needle-free drug delivery device market majorly consists of the players such NuGen Medical Devices Inc, NovaXS Biotech, GlaxoSmithKline, AstraZeneca, Roche, Boehringer Ingelheim, Merck, Cipla, Novartis, Teva Pharmaceuticals, Omron Healthcare, Sumitomo Pharma Co., Ltd
Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.
Based on geography, the needle-free drug delivery device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global needle-free drug delivery device market. Asia Pacific is expected to register the highest CAGR in the needle-free drug delivery device market during 2022–2030.
Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others.
By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.
Increasing prevalence of chronic diseases and increasing needlestick injuries propels the needle-free drug delivery devices market growth. However, the high cost of development as compare to injections hinders the growth of the market.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Needle-Free Drug Delivery Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Needle-Free Drug Delivery Devices Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Needle-Free Drug Delivery Devices Market - Global Market Analysis
6.1 Needle-Free Drug Delivery Devices - Global Market Overview
6.2 Needle-Free Drug Delivery Devices - Global Market and Forecast to 2031
7. Needle-Free Drug Delivery Devices Market – Revenue Analysis (USD Million) – By Type, 2021-2031
7.1 Overview
7.2 Jet Injectors
7.3 Transdermal Patch
7.4 Inhaler
7.5 Novel Needle-free
7.6 Others
8. Needle-Free Drug Delivery Devices Market – Revenue Analysis (USD Million) – By Application, 2021-2031
8.1 Overview
8.2 Vaccination
8.3 Pain Management
8.4 Insulin Delivery
8.5 Others
9. Needle-Free Drug Delivery Devices Market - Revenue Analysis (USD Million), 2021-2031 – Geographical Analysis
9.1 North America
9.1.1 North America Needle-Free Drug Delivery Devices Market Overview
9.1.2 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts to 2031
9.1.3 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Type
9.1.4 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Application
9.1.5 North America Needle-Free Drug Delivery Devices Market Revenue and Forecasts and Analysis - By Countries
9.1.5.1 United States Needle-Free Drug Delivery Devices Market
9.1.5.1.1 United States Needle-Free Drug Delivery Devices Market, by Type
9.1.5.1.2 United States Needle-Free Drug Delivery Devices Market, by Application
9.1.5.2 Canada Needle-Free Drug Delivery Devices Market
9.1.5.2.1 Canada Needle-Free Drug Delivery Devices Market, by Type
9.1.5.2.2 Canada Needle-Free Drug Delivery Devices Market, by Application
9.1.5.3 Mexico Needle-Free Drug Delivery Devices Market
9.1.5.3.1 Mexico Needle-Free Drug Delivery Devices Market, by Type
9.1.5.3.2 Mexico Needle-Free Drug Delivery Devices Market, by Application
Note - Similar analysis would be provided for below mentioned regions/countries
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Rest of Europe
9.3 Asia-Pacific
9.3.1 Australia
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 South Korea
9.3.6 Rest of Asia-Pacific
9.4 Middle East and Africa
9.4.1 South Africa
9.4.2 Saudi Arabia
9.4.3 U.A.E
9.4.4 Rest of Middle East and Africa
9.5 South and Central America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Rest of South and Central America
10. Industry Landscape
10.1 Mergers and Acquisitions
10.2 Agreements, Collaborations, Joint Ventures
10.3 New Product Launches
10.4 Expansions and Other Strategic Developments
11. Competitive Landscape
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration
12. Needle-Free Drug Delivery Devices Market - Key Company Profiles
12.1 NuGen Medical Devices
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
Note - Similar information would be provided for below list of companies
12.2 NovaXS Biotech
12.3 GlaxoSmithKline
12.4 AstraZeneca
12.5 Roche
12.6 Boehringer Ingelheim
12.7 Merck
12.8 Cipla
12.9 Novartis
12.10 Teva Pharmaceuticals
12.11 Omron Healthcare
12.12 Sumitomo Pharma Co. Ltd
13. Appendix
13.1 Glossary
13.2 About The Insight Partners
13.3 Market Intelligence Cloud
The List of Companies - Needle-Free Drug Delivery Devices Market
- NuGen Medical Devices Inc
- NovaXS Biotech
- GlaxoSmithKline
- AstraZeneca
- Roche
- Boehringer Ingelheim
- Merck
- Cipla
- Novartis
- Teva Pharmaceuticals
- Omron Healthcare
- Sumitomo Pharma Co., Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Needle-Free Drug Delivery Devices Market
May 2024
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
May 2024
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
May 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
May 2024
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
May 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
May 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
May 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For